CADRE HOLDINGS INC (CDRE) Fundamental Analysis & Valuation

NYSE:CDRE • US12763L1052

Current stock price

31.795 USD
+0.19 (+0.59%)
Last:

This CDRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CDRE Profitability Analysis

1.1 Basic Checks

  • In the past year CDRE was profitable.
  • In the past year CDRE had a positive cash flow from operations.
  • Each year in the past 5 years CDRE has been profitable.
  • CDRE had a positive operating cash flow in each of the past 5 years.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

1.2 Ratios

  • The Return On Assets of CDRE (5.73%) is better than 70.89% of its industry peers.
  • CDRE has a Return On Equity of 13.89%. This is in the better half of the industry: CDRE outperforms 74.68% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.75%, CDRE is in the better half of the industry, outperforming 65.82% of the companies in the same industry.
  • CDRE had an Average Return On Invested Capital over the past 3 years of 9.57%. This is in line with the industry average of 9.24%.
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROIC 7.75%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

1.3 Margins

  • CDRE has a better Profit Margin (7.23%) than 67.09% of its industry peers.
  • CDRE's Profit Margin has declined in the last couple of years.
  • CDRE has a better Operating Margin (12.30%) than 74.68% of its industry peers.
  • CDRE's Operating Margin has declined in the last couple of years.
  • CDRE has a better Gross Margin (42.54%) than 81.01% of its industry peers.
  • In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

5

2. CDRE Health Analysis

2.1 Basic Checks

  • CDRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CDRE has more shares outstanding
  • Compared to 5 years ago, CDRE has more shares outstanding
  • Compared to 1 year ago, CDRE has a worse debt to assets ratio.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • CDRE has an Altman-Z score of 3.38. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
  • CDRE's Altman-Z score of 3.38 is in line compared to the rest of the industry. CDRE outperforms 49.37% of its industry peers.
  • CDRE has a debt to FCF ratio of 5.45. This is a neutral value as CDRE would need 5.45 years to pay back of all of its debts.
  • CDRE has a Debt to FCF ratio of 5.45. This is in the better half of the industry: CDRE outperforms 70.89% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that CDRE is somewhat dependend on debt financing.
  • CDRE's Debt to Equity ratio of 0.92 is on the low side compared to the rest of the industry. CDRE is outperformed by 68.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Altman-Z 3.38
ROIC/WACC0.78
WACC9.95%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • CDRE has a Current Ratio of 3.50. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
  • CDRE's Current ratio of 3.50 is fine compared to the rest of the industry. CDRE outperforms 65.82% of its industry peers.
  • A Quick Ratio of 2.54 indicates that CDRE has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.54, CDRE is doing good in the industry, outperforming 74.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 2.54
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

6

3. CDRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 18.89% over the past year.
  • Measured over the past years, CDRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.75% on average per year.
  • Looking at the last year, CDRE shows a small growth in Revenue. The Revenue has grown by 7.53% in the last year.
  • CDRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.57% yearly.
EPS 1Y (TTM)18.89%
EPS 3Y9.72%
EPS 5Y-1.75%
EPS Q2Q%-15.62%
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.17% on average over the next years. This is a very strong growth
  • CDRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y39.94%
EPS Next 2Y24.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.25%
Revenue Next 2Y12.43%
Revenue Next 3Y11.28%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

6

4. CDRE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 29.71, CDRE can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, CDRE is valued a bit cheaper than the industry average as 75.95% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.54, CDRE is valued at the same level.
  • A Price/Forward Earnings ratio of 21.23 indicates a rather expensive valuation of CDRE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CDRE indicates a rather cheap valuation: CDRE is cheaper than 84.81% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, CDRE is valued at the same level.
Industry RankSector Rank
PE 29.71
Fwd PE 21.23
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CDRE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CDRE is cheaper than 81.01% of the companies in the same industry.
  • CDRE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CDRE is cheaper than 93.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.9
EV/EBITDA 16.42
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • CDRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CDRE has a very decent profitability rating, which may justify a higher PE ratio.
  • CDRE's earnings are expected to grow with 24.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y24.17%
EPS Next 3YN/A

4

5. CDRE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.25%, CDRE has a reasonable but not impressive dividend return.
  • In the last 3 months the price of CDRE has falen by -24.63%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.36, CDRE pays a better dividend. On top of this CDRE pays more dividend than 89.87% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.89, CDRE is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.25%

5.2 History

  • CDRE has been paying a dividend for over 5 years, so it has already some track record.
  • CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • CDRE pays out 35.00% of its income as dividend. This is a sustainable payout ratio.
DP35%
EPS Next 2Y24.17%
EPS Next 3YN/A
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CDRE Fundamentals: All Metrics, Ratios and Statistics

CADRE HOLDINGS INC

NYSE:CDRE (3/24/2026, 1:55:49 PM)

31.795

+0.19 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-10
Earnings (Next)05-04
Inst Owners80.08%
Inst Owner Change6.94%
Ins Owners28.59%
Ins Owner Change-0.37%
Market Cap1.36B
Revenue(TTM)610.31M
Net Income(TTM)44.14M
Analysts80
Price Target50.32 (58.26%)
Short Float %5.71%
Short Ratio5.94
Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Yearly Dividend0.37
Dividend Growth(5Y)N/A
DP35%
Div Incr Years1
Div Non Decr Years3
Ex-Date01-30
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.17%
Min EPS beat(2)-34.15%
Max EPS beat(2)1.81%
EPS beat(4)3
Avg EPS beat(4)16.71%
Min EPS beat(4)-34.15%
Max EPS beat(4)87.91%
EPS beat(8)5
Avg EPS beat(8)8.5%
EPS beat(12)9
Avg EPS beat(12)18.19%
EPS beat(16)10
Avg EPS beat(16)13.36%
Revenue beat(2)0
Avg Revenue beat(2)-6.82%
Min Revenue beat(2)-10.38%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-2.22%
Min Revenue beat(4)-10.38%
Max Revenue beat(4)4.48%
Revenue beat(8)4
Avg Revenue beat(8)-2.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.99%
Revenue beat(16)11
Avg Revenue beat(16)-0.01%
PT rev (1m)1.37%
PT rev (3m)1.72%
EPS NQ rev (1m)-60.27%
EPS NQ rev (3m)-60.27%
EPS NY rev (1m)7%
EPS NY rev (3m)7%
Revenue NQ rev (1m)4.25%
Revenue NQ rev (3m)4.25%
Revenue NY rev (1m)1.58%
Revenue NY rev (3m)9.28%
Valuation
Industry RankSector Rank
PE 29.71
Fwd PE 21.23
P/S 2.23
P/FCF 23.9
P/OCF 21.33
P/B 4.27
P/tB 63.44
EV/EBITDA 16.42
EPS(TTM)1.07
EY3.37%
EPS(NY)1.5
Fwd EY4.71%
FCF(TTM)1.33
FCFY4.18%
OCF(TTM)1.49
OCFY4.69%
SpS14.28
BVpS7.44
TBVpS0.5
PEG (NY)0.74
PEG (5Y)N/A
Graham Number13.38
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROCE 11.28%
ROIC 7.75%
ROICexc 9.51%
ROICexgc 20.95%
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
FCFM 9.31%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
ROICexc(3y)12.43%
ROICexc(5y)12.27%
ROICexgc(3y)27.27%
ROICexgc(5y)26.53%
ROCE(3y)13.93%
ROCE(5y)14.36%
ROICexgc growth 3Y25.09%
ROICexgc growth 5Y-11.22%
ROICexc growth 3Y20.63%
ROICexc growth 5Y-11.53%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Debt/EBITDA 3.13
Cap/Depr 36.79%
Cap/Sales 1.12%
Interest Coverage 4.21
Cash Conversion 68%
Profit Quality 128.79%
Current Ratio 3.5
Quick Ratio 2.54
Altman-Z 3.38
F-Score6
WACC9.95%
ROIC/WACC0.78
Cap/Depr(3y)38.02%
Cap/Depr(5y)32.68%
Cap/Sales(3y)1.17%
Cap/Sales(5y)1.03%
Profit Quality(3y)124.37%
Profit Quality(5y)277.85%
High Growth Momentum
Growth
EPS 1Y (TTM)18.89%
EPS 3Y9.72%
EPS 5Y-1.75%
EPS Q2Q%-15.62%
EPS Next Y39.94%
EPS Next 2Y24.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%
Revenue Next Year18.25%
Revenue Next 2Y12.43%
Revenue Next 3Y11.28%
Revenue Next 5YN/A
EBIT growth 1Y3.13%
EBIT growth 3Y52.65%
EBIT growth 5Y6.18%
EBIT Next Year87.72%
EBIT Next 3Y33.16%
EBIT Next 5YN/A
FCF growth 1Y117.74%
FCF growth 3Y10.69%
FCF growth 5Y6.91%
OCF growth 1Y100.48%
OCF growth 3Y11.14%
OCF growth 5Y7%

CADRE HOLDINGS INC / CDRE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CADRE HOLDINGS INC (CDRE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CDRE.


What is the valuation status of CADRE HOLDINGS INC (CDRE) stock?

ChartMill assigns a valuation rating of 6 / 10 to CADRE HOLDINGS INC (CDRE). This can be considered as Fairly Valued.


Can you provide the profitability details for CADRE HOLDINGS INC?

CADRE HOLDINGS INC (CDRE) has a profitability rating of 6 / 10.


How financially healthy is CADRE HOLDINGS INC?

The financial health rating of CADRE HOLDINGS INC (CDRE) is 5 / 10.


Can you provide the expected EPS growth for CDRE stock?

The Earnings per Share (EPS) of CADRE HOLDINGS INC (CDRE) is expected to grow by 39.94% in the next year.